CVE-2026-1031: Multiple vulnerabilities affect IBM License Key Server Administration and Reporting Tool and IBM LKS Administration Agent
IBM · Common Licensing
Vendor fix available · Affected: IBM Common Licensing · Exploitation: unlikely (under 1%)
Not in CyberSIXT coverage yet: no article names this CVE. This page shows the public record.
Higher than 20% of scored CVEs
DescriptionCVE.org
IBM Common Licensing Agent 9.0, Agent 9.0.0.1, Agent 9.0.0.2, ART 9.0, ART 9.0.0.1, and ART 9.0.0.2 is vulnerable to cross-site scripting. This vulnerability allows an unauthenticated attacker to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session.
Affected products1
From the CVE record. A product or version that is not listed is unknown, not unaffected.
- IBM · Common LicensingAgent 9.0; Agent 9.0.0.1; Agent 9.0.0.2; ART 9.0; ART 9.0.0.1; ART 9.0.0.2
On the Atlas
Every published CVE is on the CyberSIXT Atlas, grouped by weakness, vendor and month.
- Exploitation
- Unlikely (under 1%). EPSS under 1%, or no score yet.
- CISA KEV
- Not listed
- Public check
- No public nuclei template
- Weakness
- Cross-site Scripting
- Vendor
- IBM
- Published
- September 2026
CoverageNo articles yet
No CyberSIXT article names CVE-2026-1031 yet, so there is no coverage timeline, action brief or change log for it. Everything on this page comes from the public CVE record, CISA KEV, EPSS and the nuclei template index. Search the archive or see the CVEs in the news.